Detalhe da pesquisa
1.
The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease.
Ann Rheum Dis
; 82(10): 1248-1257, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37495237
2.
[Management of hyperuricemia in chronic kidney disease]. / Hyperuricémie et maladie rénale : prise en charge.
Rev Med Suisse
; 18(771): 379-384, 2022 Mar 02.
Artigo
em Francês
| MEDLINE | ID: mdl-35235261
3.
2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout.
Ann Rheum Dis
; 79(1): 31-38, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31167758
4.
Systematic genetic analysis of early-onset gout: ABCG2 is the only associated locus.
Rheumatology (Oxford)
; 59(9): 2544-2549, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31998961
5.
Hydrogen sulfide inhibits NLRP3 inflammasome activation and reduces cytokine production both in vitro and in a mouse model of inflammation.
J Biol Chem
; 293(7): 2546-2557, 2018 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29279328
6.
Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018.
Ann Rheum Dis
; 78(7): 872-878, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30712015
7.
Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout.
Ann Rheum Dis
; 78(11): 1592-1600, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31501138
8.
The role of IL-1 in gout: from bench to bedside.
Rheumatology (Oxford)
; 57(suppl_1): i12-i19, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29272514
9.
Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study).
Ann Rheum Dis
; 76(5): 811-820, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27821644
10.
Intracellular ATP Decrease Mediates NLRP3 Inflammasome Activation upon Nigericin and Crystal Stimulation.
J Immunol
; 195(12): 5718-24, 2015 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26546608
11.
Interleukin-6 and chondrocyte mineralisation act in tandem to promote experimental osteoarthritis.
Ann Rheum Dis
; 75(7): 1372-9, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26253096
12.
Multi-energy photon-counting computed tomography versus other clinical imaging techniques for the identification of articular calcium crystal deposition.
Rheumatology (Oxford)
; 60(5): 2483-2485, 2021 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33560293
13.
Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout.
Rheumatology (Oxford)
; 55(8): 1421-30, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27094595
14.
Why better treatment of gout is needed.
Clin Exp Rheumatol
; 34(4 Suppl 98): 63-5, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27586807
15.
PASS Syndrome: An IL-1-Driven Autoinflammatory Disease.
Dermatology
; 232(2): 254-8, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26919742
16.
[Spondylarthropathies: conventional treatments and anti-TNF]. / Spondyloarthropathies: traitements conventionnels et anti-TNF.
Rev Med Suisse
; 12(509): 507-8, 510-1, 2016 Mar 09.
Artigo
em Francês
| MEDLINE | ID: mdl-27089640
17.
[MRI of axial spondyloarthritis: diagnostic role and pitfalls]. / IRM dans le diagnostic des spondyloarthrites axiales: utilité et pièges diagnostiques.
Rev Med Suisse
; 12(509): 495-6, 498-502, 2016 Mar 09.
Artigo
em Francês
| MEDLINE | ID: mdl-27089638
18.
Interleukin-1 as a therapeutic target in gout.
Curr Opin Rheumatol
; 27(2): 156-63, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25633244
19.
Anti-tumor necrosis factor drug survival in axial spondyloarthritis is independent of the classification criteria.
Rheumatol Int
; 35(2): 295-302, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25070142
20.
Periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome is linked to dysregulated monocyte IL-1ß production.
J Allergy Clin Immunol
; 131(6): 1635-43, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23006543